July 2023 - PRECISIONadvisors

White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions

Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.

LEARN MORE

White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutionsllewin2023-11-09T08:28:26-05:00

What Changes Can We Expect on Health Care in the Coming General Elections in Spain?

What changes can we expect on health care in the coming general elections in Spain? Following up on our previous post, we have some insights on what lies ahead for the coming general elections in Spain.

LEARN MORE

What Changes Can We Expect on Health Care in the Coming General Elections in Spain?llewin2023-07-18T12:37:04-04:00

On Demand: NICE Early Scientific Advice: When, Why, and How!

Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.

LEARN MORE

On Demand: NICE Early Scientific Advice: When, Why, and How!llewin2023-11-09T08:06:57-05:00